<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC316827/" ref="ordinalpos=3897&amp;ncbi_uid=406015&amp;link_uid=PMC316827" image-link="/pmc/articles/PMC316827/figure/F9/" class="imagepopup">Figure 9.  From: Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK <span class="highlight" style="background-color:">pathway</span>. </a></div><br /><div class="p4l_captionBody"> Model for the antagonistic action of hormone-activated nuclear receptors on AP-1 activity through the inhibition of the JNK signal transduction pathway. Activation of gene transcription by either nuclear hormone receptors or AP-1 relays on an activation step: hormone (▴) binding for nuclear receptors and c-Jun phosphorylation on Ser-63/73 (▪) for AP-1. According to our data, upon hormone activation nuclear receptors block the induction of the JNK signaling pathway and, in consequence, c-Jun amino-terminal phosphorylation. By this mechanism, steroid/thyroid hormones and RARs may antagonize AP-1 activity and inhibit expression of AP-1 target genes.</div></div>